Supplement NDI Notification Guidance Cruel To Firms On Animal Testing
This article was originally published in The Rose Sheet
Executive Summary
CFSAN’s latest draft guidance for NDI notifications does little to address the supplement industry’s concerns, and the “worst” aspect is a recommendation to test ingredients on animals when historical use data is not available, says a New Hope Network analyst.